Literature DB >> 6967568

'Activation-labile' glucocorticoid-receptor complexes of a steroid-resistant variant of CEM-C7 human lymphoid cells.

T J Schmidt, J M Harmon, E B Thompson.   

Abstract

For cytoplasmic glucocorticoid-receptor complexes to enter and accumulate in the nucleus a temperature-dependent event, 'activation' is required. Activation can be achieved in vitro by increased ionic strength, dilution or gel filtration and is manifested by an increased affinity of steroid-receptor complex for DNA and an altered elution profile from ion-exchange resins. Munck and Foley have shown that activated complexes isolated from thymocytes elute from DEAE-cellulose in a manner identical to complexes activated in vitro. We report here that DEAE-cellulose chromatography of steroid-receptor complexes from CEM-C7, a cloned human leukaemic T-cell line sensitive to the cytolytic action of glucocorticoids, and its steroid-resistant subclone 4R4 demonstrated that steroid receptors of clone 4R4 cannot form stable activated complexes. This defines a new defect in receptor action, activation lability (r+act1), which is unlike either the r-, r+nt-, or r+nti phenotypes previously described for mouse lymphoid variants.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967568     DOI: 10.1038/286507a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  14 in total

1.  Estradiol receptor has proteolytic activity that is responsible for its own transformation.

Authors:  G A Puca; C Abbondanza; V Nigro; I Armetta; N Medici; A M Molinari
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  Resistance to HIV-1 infection by CD4-positive lymphoid cells that vary in their glucocorticoid receptors and responses.

Authors:  S Kawa; M W Cloyd; E B Thompson
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-04       Impact factor: 2.416

3.  Glucocorticoid hormone resistance during primate evolution: receptor-mediated mechanisms.

Authors:  G P Chrousos; D Renquist; D Brandon; C Eil; M Pugeat; R Vigersky; G B Cutler; D L Loriaux; M B Lipsett
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

4.  nti glucocorticoid receptor transcripts lack sequences encoding the amino-terminal transcriptional modulatory domain.

Authors:  E S Dieken; E U Meese; R L Miesfeld
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

5.  A mutation that causes lability of the androgen receptor under conditions that normally promote transformation to the DNA-binding state.

Authors:  W J Kovacs; J E Griffin; D D Weaver; B R Carlson; J D Wilson
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

6.  Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease.

Authors:  G P Chrousos; A Vingerhoeds; D Brandon; C Eil; M Pugeat; M DeVroede; D L Loriaux; M B Lipsett
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

7.  Isolation and characterization of dexamethasone-resistant mutants from human lymphoid cell line CEM-C7.

Authors:  J M Harmon; E B Thompson
Journal:  Mol Cell Biol       Date:  1981-06       Impact factor: 4.272

8.  Primary cortisol resistance associated with a thermolabile glucocorticoid receptor in a patient with fatigue as the only symptom.

Authors:  M Brönnegård; S Werner; J A Gustafsson
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

Review 9.  Glucocorticoid receptors in human leukemias and related diseases.

Authors:  E B Thompson; J R Smith; S Bourgeois; J M Harmon
Journal:  Klin Wochenschr       Date:  1985-08-01

10.  Familial incomplete male pseudohermaphroditism associated with impaired nuclear androgen retention. Studies in cultured skin fibroblasts.

Authors:  C Eil
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.